Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Spark Therapeutics
Spark Therapeutics
(ONCE)
Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases. It is a subsidiary of Hoffmann-La Roche.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Luxturna
Voretigene neparvovec
2017-12-19
Retinitis pigmentosa
,
Leber congenital amaurosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voretigene neparvovec
leber congenital amaurosis
,
retinal dystrophies
,
blindness
,
retinitis pigmentosa
Bevifimod
neoplasms
,
lung neoplasms
,
large b-cell lymphoma diffuse
,
waldenstrom macroglobulinemia
,
b-cell lymphoma
,
pancreatic ductal carcinoma
,
colorectal neoplasms
,
recurrence
,
neoplasm metastasis
,
prostatic neoplasms
,
liver neoplasms
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
non-small-cell lung carcinoma
,
mantle-cell lymphoma
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
non-hodgkin lymphoma
,
adenocarcinoma
,
stomach neoplasms
,
leukemia
,
lymphoid leukemia
,
esophageal neoplasms
Globulin, immune
non-hodgkin lymphoma
,
lymphoma
,
large b-cell lymphoma diffuse
,
leukemia
,
myeloid leukemia acute
Demand
acute pain
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use